Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

Stopped BIOTRONIK received FDA approval to transition the ongoing Sentus QP Study to a new EP PASSION real-world data methodology.

Conditions

• Heart Failure

Interventions

• DEVICE: Sentus QP left ventricular lead

Sponsor

Biotronik SE & Co. KG

Collaborators

• [object Object]